Search research articles
Contact Us
Filters
Showing results (11-20 of 295) with videos related to
Page
of 30
Sort By:
Expert Opinion on Therapeutic Targets
|
December 16, 2014
The η-class carbonic anhydrases as drug targets for antimalarial agents
Claudiu T Supuran, Clemente Capasso
Journal of Enzyme Inhibition and Medicinal Chemistry
|
June 30, 2016
New light on bacterial carbonic anhydrases phylogeny based on the analysis of signal peptide sequences
Claudiu T Supuran, Clemente Capasso
Journal of Enzyme Inhibition and Medicinal Chemistry
|
May 1, 2013
Sulfa and trimethoprim-like drugs - antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors
Clemente Capasso, Claudiu T Supuran
Expert Opinion on Therapeutic Patents
|
August 19, 2020
Antibacterial carbonic anhydrase inhibitors: an update on the recent literature
Claudiu T Supuran, Clemente Capasso
Expert Opinion on Therapeutic Patents
|
March 20, 2024
Carbonic anhydrase and bacterial metabolism: a chance for antibacterial drug discovery
Clemente Capasso, Claudiu T Supuran
Expert Opinion on Therapeutic Patents
|
June 6, 2024
Biomedical applications of prokaryotic carbonic anhydrases: an update
Clemente Capasso, Claudiu T Supuran
Expert Opinion on Therapeutic Patents
|
August 29, 2019
Novel method of treating macular degeneration: a patent evaluation (WO2018/107005)
Clemente Capasso, Jean-Yves Winum
Current Topics in Medicinal Chemistry
|
January 5, 2017
Inhibition of Bacterial Carbonic Anhydrases as a Novel Approach to Escape Drug Resistance
Clemente Capasso, Claudiu T Supuran
Expert Opinion on Therapeutic Patents
|
February 28, 2013
Novel antibody to a carbonic anhydrase: patent evaluation of WO2011138279A1
Jean-Yves Winum, Clemente Capasso
Metabolites
|
November 16, 2017
An Overview of the Bacterial Carbonic Anhydrases
Claudiu T Supuran, Clemente Capasso
Page
of 30
Search research articles
Search
Showing results (11-20 of 295) with videos related to
Sort By:
Page
of 30
Expert Opinion on Therapeutic Targets
|
December 16, 2014
The η-class carbonic anhydrases as drug targets for antimalarial agents
Claudiu T Supuran, Clemente Capasso
Journal of Enzyme Inhibition and Medicinal Chemistry
|
June 30, 2016
New light on bacterial carbonic anhydrases phylogeny based on the analysis of signal peptide sequences
Claudiu T Supuran, Clemente Capasso
Journal of Enzyme Inhibition and Medicinal Chemistry
|
May 1, 2013
Sulfa and trimethoprim-like drugs - antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors
Clemente Capasso, Claudiu T Supuran
Expert Opinion on Therapeutic Patents
|
August 19, 2020
Antibacterial carbonic anhydrase inhibitors: an update on the recent literature
Claudiu T Supuran, Clemente Capasso
Expert Opinion on Therapeutic Patents
|
March 20, 2024
Carbonic anhydrase and bacterial metabolism: a chance for antibacterial drug discovery
Clemente Capasso, Claudiu T Supuran
Expert Opinion on Therapeutic Patents
|
June 6, 2024
Biomedical applications of prokaryotic carbonic anhydrases: an update
Clemente Capasso, Claudiu T Supuran
Expert Opinion on Therapeutic Patents
|
August 29, 2019
Novel method of treating macular degeneration: a patent evaluation (WO2018/107005)
Clemente Capasso, Jean-Yves Winum
Current Topics in Medicinal Chemistry
|
January 5, 2017
Inhibition of Bacterial Carbonic Anhydrases as a Novel Approach to Escape Drug Resistance
Clemente Capasso, Claudiu T Supuran
Expert Opinion on Therapeutic Patents
|
February 28, 2013
Novel antibody to a carbonic anhydrase: patent evaluation of WO2011138279A1
Jean-Yves Winum, Clemente Capasso
Metabolites
|
November 16, 2017
An Overview of the Bacterial Carbonic Anhydrases
Claudiu T Supuran, Clemente Capasso
Page
of 30